-
LENZ Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
LENZ Therapeutics (LENZ)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 41.16 mm | 41.16 mm | 41.16 mm | 41.16 mm | 41.16 mm | 41.16 mm |
Cash burn (monthly) | 14.33 mm | 140.67 k | 4.32 mm | 5.70 mm | 3.53 mm | 5.94 mm |
Cash used (since last report) | 57.67 mm | 566.09 k | 17.36 mm | 22.93 mm | 14.19 mm | 23.91 mm |
Cash remaining | -16.51 mm | 40.59 mm | 23.80 mm | 18.23 mm | 26.97 mm | 17.25 mm |
Runway (months of cash) | -1.2 | 288.6 | 5.5 | 3.2 | 7.6 | 2.9 |
13F holders | Current |
---|---|
Total holders | 82 |
Opened positions | 24 |
Closed positions | 10 |
Increased positions | 20 |
Reduced positions | 16 |
13F shares | Current |
---|---|
Total value | 433.50 bn |
Total shares | 27.61 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Ra Capital Management | 4.18 mm | $99.21 bn |
Falcon Edge Capital | 3.61 mm | $85.75 bn |
Alpha Wave Ventures GP | 3.61 mm | $80.41 mm |
Versant Venture Capital VI | 2.10 mm | $45.93 mm |
Ridgeback Capital Investments | 1.95 mm | $42.57 mm |
Samsara BioCapital | 1.21 mm | $3.84 mm |
Samsara BioCapital | 1.21 mm | $28.69 bn |
Vanguard | 1.12 mm | $26.56 bn |
72 Investment | 1.02 mm | $24.16 bn |
Sectoral Asset Management | 977.25 k | $23.20 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Jan 25 | Evert B. Schimmelpennink | Stock Option Common Stock | Grant | Acquire A | No | No | 26.34 | 279,100 | 7.35 mm | 279,100 |
9 Jan 25 | Daniel R. Chevallard | Stock Option Common Stock | Grant | Acquire A | No | No | 26.34 | 70,444 | 1.86 mm | 70,444 |
9 Jan 25 | Shawn Olsson | Stock Option Common Stock | Grant | Acquire A | No | No | 26.34 | 80,100 | 2.11 mm | 80,100 |
9 Jan 25 | Marc Odrich | Stock Option Common Stock | Grant | Acquire A | No | No | 26.34 | 80,100 | 2.11 mm | 80,100 |
16 Dec 24 | Shawn Olsson | Common Stock | Option exercise | Acquire M | No | No | 2.08 | 3,333 | 6.93 k | 3,333 |
16 Dec 24 | Shawn Olsson | Stock Option Common Stock | Option exercise | Dispose M | No | No | 2.08 | 3,333 | 6.93 k | 64,641 |